Revolution Medicines (RVMD) counsel sells 2,157 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Revolution Medicines, Inc. General Counsel Jeff Cislini reported an open-market sale of 2,157 shares of common stock at a weighted average price of $156.1191 per share. The trade was executed under a Rule 10b5-1 instruction letter to cover tax withholding on vested RSUs. After this transaction, he holds 56,521 shares, including 43,514 restricted stock units and 160 shares acquired through the company’s Employee Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,157 shares ($336,749)
Net Sell
1 txn
Insider
Cislini Jeff
Role
General Counsel
Sold
2,157 shs ($337K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,157 | $156.1191 | $337K |
Holdings After Transaction:
Common Stock — 56,521 shares (Direct, null)
Footnotes (1)
- Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8251. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 43,514 RSUs. Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
Key Figures
Shares sold: 2,157 shares
Sale price: $156.1191 per share
Holdings after sale: 56,521 shares
+4 more
7 metrics
Shares sold
2,157 shares
Open-market sale of common stock
Sale price
$156.1191 per share
Weighted average sale price
Holdings after sale
56,521 shares
Total common stock held following transaction
RSUs included in holdings
43,514 RSUs
Restricted stock units included in post-transaction holdings
ESPP shares included
160 shares
Shares acquired under Employee Stock Purchase Plan on May 31, 2026
10b5-1 plan adoption date
May 31, 2023
Rule 10b5-1 instruction letter adoption
Transaction date
June 16, 2026
Date of open-market sale
Key Terms
Rule 10b5-1, restricted stock units ("RSUs"), weighted average price, Employee Stock Purchase Plan, +1 more
5 terms
Rule 10b5-1 regulatory
"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
restricted stock units ("RSUs") financial
"to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Purchase Plan financial
"Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did RVMD General Counsel Jeff Cislini report in this Form 4 filing?
Jeff Cislini reported selling 2,157 shares of Revolution Medicines common stock in an open-market transaction. The reported weighted average sale price was $156.1191 per share, with the trade disclosed as part of his routine SEC reporting obligations.
Was the RVMD insider stock sale by Jeff Cislini pre-planned under Rule 10b5-1?
Yes. The sale was made under a Rule 10b5-1 instruction letter adopted on May 31, 2023. Such plans pre-arrange trades, helping insiders systematically sell shares without timing decisions based on nonpublic information.